Most Recent
S&P Global will pay $215 million to settle six consolidated class actions brought by investors over toxic CDOs, a figure revealed by the Federal Court on Thursday despite calls that it be kept secret.
Lawyers wants to expand the class action brought against the Ford Motor Company of Australia over allegedly defective Powershift transmissions, seeking court approval to increase the class size and bring new unconscionable conduct claims.
Six major car companies indicated Tuesday they were open to a quick settlement of class actions brought on behalf of potentially hundreds of thousands of Australian drivers whose cars were fitted with defective and deadly Takata airbags.
AstraZeneca is appealing a Fair Work Commission decision that workers are guaranteed 10 days' sick leave under the National Employment Standards regardless of how long their working day is.
The Full Federal Court will hear arguments next week in an appeal by the ACCC over an alleged laundry detergent cartel, the first so-called hub and spoke case brought by the competition regulator.
Chain logistics company Brambles is facing a second class action alleging it breached its continuous disclosure obligations by failing to revise its overly rosy 2017 financial forecast on several occasions.
A judge has denied a Westpac unit's bid to strike allegations that it knew about a $1.9 million Ponzi scheme from a class action alleging the bank aided the Ponzi schemer's illegal conduct.
When it comes to bet-the-company matters that keep corporate counsel awake at night, intellectual property disputes often rank at the top of the list. And these eight law firms are the ones companies turned to the most last year when facing a courtroom battle over their IP.
Slater and Gordon has filed a shareholder class action against Brambles over its allegedly misleading and overly rosy 2017 financial forecasts, beating rival Maurice Blackburn to the punch almost 10 months after it announced it was investigating a shareholder class action against the logistics company.
Ophthalmic diagnostic device manufacture ObjectiVision can't file amended claims for damages following a trial in a copyright and contract case against the University of Sydney, with a judge saying the school would be "severely prejudiced" if the new claims were allowed.